Singapore state investor Temasek and private equity major Warburg Pincus are gearing up to sell healthcare supply chain management firm Global Healthcare Exchange (GHX) at a valuation of nearly $5 billion, the Financial Times reported, citing people familiar with the matter.
According to the report, GHX has engaged with advisors to oversee the sale process, which could result in partial divestment to a full exit. GHX is expected to receive formal bids in the latter half of the year.
GHX, which Temasek first invested in back in 2017 at a valuation of $1.8 billion, provides cloud-based inventory, supply chain, and payment management solutions for healthcare providers and suppliers.
Warburg Pincus acquired a minority interest in the company in 2021 by investing $500 million. The investment provided an exit to minority investor Thoma Bravo, which acquired GHX in 2014.
Founded in 2000, GHX pioneered healthcare’s leading cloud-based supply chain network, which today connects tens of thousands of healthcare organisations across the globe. GHX said it helps the healthcare ecosystem to move faster, operate more intelligently, and achieve greater outcomes.
The potential sale of GHX is expected to attract interest from both private equity and strategic buyers, although a deal is not guaranteed, according to sources cited by the FT.
